Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for aGVHD Prevention in HSCT
NCT05149365Phase 3Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in Acute Graft-Versus-Host Disease (aGvHD), sponsored by First Affiliated Hospital of Soochow University. Started Dec 2021; status: completed.
02
Drugs
sitagliptin
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT05149365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05149365.